查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092318

RNA分析與轉錄組學市場－2026-2032年全球市場預測

RNA Analysis/Transcriptomics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，RNA 分析和轉錄組學市場將成長至 208.4 億美元，複合年成長率為 12.26%。

主要市場統計數據
基準年 2025 92.7億美元
預計年份：2026年 103.9億美元
預測年份 2032 208.4億美元
複合年成長率 (%) 12.26%

RNA分析和轉錄組學正從專門的研究工作流程轉變為生命科學、臨床研究、藥物研發、農業和公共衛生等領域的核心決策工具。透過測量RNA表現、可變剪接、融合轉錄物、非編碼RNA和單細胞基因活性，轉錄組學技術幫助研究人員了解基因組在組織、疾病狀態、發育階段和治療反應中的功能表現。次世代定序、定量PCR、數位PCR、空間轉錄組學、單細胞RNA定序、長讀長定序以及將複雜的分子訊號轉化為可操作的生物學見解的生物資訊流程，共同推動了這一領域的發展。

精準醫療、生物標記發現、免疫學研究、腫瘤譜分析、感染疾病監測、罕見疾病研究以及多體學整合等領域的興起進一步推動了對轉錄組學的需求。 RNA定序和轉錄組分析正被擴大用於識別治療標靶、對患者進行分層、監測訊號通路活性以及評估藥物反應。同時，實驗室也更加重視可重複性、檢體品質、樣品製備建置、安全的資料管理以及標準化的運算流程。隨著轉錄組學在轉化和臨床研究中日益普及，其成功取決於分析深度、擴充性、法規遵循和可解釋性之間的平衡。

RNA分析領域的變革性變化

隨著工作流程從群體基因表現分析向更高解析度、更具情境感知的分子分析發展，RNA分析和轉錄組學領域正經歷著變革性的轉變。單細胞RNA定序使研究人員能夠捕捉到群體分析中常被忽略的細胞異質性，而空間轉錄組學則為基因表現數據增添了組織結構訊息。長讀長轉錄定序提高了異構體檢測、融合轉錄本辨識和轉錄本組裝的準確性，從而支持對複雜生物系統進行更全面的表徵。

人工智慧對轉錄組學的累積影響

人工智慧透過改進模式識別、特徵選擇、資料標準化、細胞類型註釋、訊號路徑解讀和預測建模，正在加速轉錄組學的發展。機器學習模型正擴大應用於RNA定序資料集，以闡明疾病特徵、對分子亞型進行分類、預測治療反應並篩選生物標記候選物。人工智慧驅動的分析在單細胞轉錄組學和空間轉錄組學中尤其重要，因為這些領域需要對高維度資料集進行高級叢集、去噪、分割以及跨樣本、平台和模態的整合。

RNA分析和轉錄組學的關鍵區域見解

在亞太地區，由於基因組基礎設施的不斷完善、生物醫學研究投入的增加、大規模的患者群體以及次世代定序在腫瘤學、感染疾病、生殖醫學和群體基因組學等領域的日益普及，RNA分析和轉錄組學正迅速發展。該地區各國正在加強定序能力、生物資訊學人才隊伍建設和轉化研究網路建設，而對經濟高效且擴充性的工作流程日益成長的需求，正推動著RNA定序和分子診斷技術的更廣泛應用。

全球轉錄組學生態系統中的關鍵群體特異性見解

隨著東協成員國加大對生物技術、感染疾病監測、腫瘤研究和基因組學學術能力的投入，東協正崛起為RNA分析和轉錄組學領域具有戰略意義的重要區域。該地區豐富的遺傳多樣性和公共衛生重點為轉錄組學研究奠定了堅實的科學基礎，跨境合作有望促進數據協調、人力資源開發以及先進定序服務的普及。

來自影響轉錄組學傳播的關鍵國家的見解

美國是RNA分析和轉錄組學領域的領先中心，這得益於其大規模的生物醫學研究經費、臨床基因組學、藥物開發、癌症研究以及先進的定序和舉措基礎設施。加拿大正透過學術研究網路、精準醫療計畫、人口調查和生物樣本庫計畫加強轉錄組學研究，並著重於符合倫理的資料管治和合作研究。墨西哥正在拓展其在感染疾病、癌症和農業生物技術領域的分子研究能力，但能否獲得先進的定序技術和培養訓練有素的生物資訊專業人員仍然是轉錄組學更廣泛應用的關鍵決定因素。巴西是拉丁美洲的重要貢獻者，這得益於其在公共衛生基因組學、感染疾病研究、腫瘤學研究、生物多樣性研究以及日益成長的定序技術方​​面的投入。

為行業領導者提供的實用建議

產業領導者應優先考慮端到端工作流程的可靠性，涵蓋從RNA樣本儲存和提取到樣品製備、定序、分析和報告的各個環節。投資自動化、品管和標準化流程可以降低變異性，提高研究和臨床環境中的可重複性。各機構也應透過採用檢驗的流程來增強其生物資訊學能力，這些流程可用於差異表達分析、單細胞RNA定序、空間轉錄組學、長讀長轉錄組學和多體學整合。

深入了解轉錄組學的調查方法

本執行摘要採用系統性的二手研究途徑編寫，重點在於與RNA分析和舉措相關的、經過檢驗的、公開可用的、有數據支持的資訊來源。該方法考慮了科學文獻、臨床研究趨勢、監管指南、公共衛生基因組學計劃、技術應用模式、學術和政府研究項目，以及來自公認的生命科學和分子診斷領域的證據。重點在於對產業趨勢進行定性檢驗，而非市場規模估算、市場佔有率或預測。

結論：RNA分析和轉錄組學的策略展望

RNA分析和轉錄組學對於理解生物功能、疾病機制、治療反應和細胞多樣性至關重要。該領域正從傳統的基因表現分析發展到單細胞、空間、長讀長和人工智慧驅動的方法，從而提供更豐富的生物學背景並增強轉化應用價值。隨著這些技術在研究、臨床實踐、農業和公共衛生等領域的應用不斷擴展，最成功的機構將把高品質的實驗室工作流程與擴充性的分析、穩健的數據管治和跨學科專業知識相結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 RNA分析與轉錄組學市場：依產品分類

  • 耗材和試劑
  • 裝置
  • 軟體服務

第8章 RNA分析與轉錄組學市場：依技術分類

  • 數位PCR
  • 微陣列
  • 次世代定序
    • 批量轉錄組學
    • 單細胞轉錄組學
      • 液滴法
      • 基於微流體技術
  • 即時PCR

第9章 RNA分析與轉錄組學市場：按RNA類型分類

  • 傳訊RNA
  • 微型RNA
  • 轉移RNA
  • 核醣體RNA

第10章 RNA分析與轉錄組學市場：依定序規模分類

  • 低吞吐量
  • 中等吞吐量
  • 高通量
  • 超高吞吐量

第11章 RNA分析與轉錄組學市場：按應用分類

  • 癌症研究
  • 藥物發現
  • 基因檢測
    • 職業篩檢
    • 疾病診斷
    • 產前和新生兒篩檢
  • 感染疾病調查
  • 工廠調查

第12章 RNA分析與轉錄組學市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章 RNA分析與轉錄組學市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章 RNA分析與轉錄組學市場：按國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Azenta, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioSkryb Genomics, Inc.
  • Curio Bioscience, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Genewiz, Inc.
  • Illumina, Inc.
  • Lexogen GmbH
  • Merck KGaA
  • Mission Bio, Inc.
  • NanoString Technologies, Inc.
  • New England Biolabs, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Parse Biosciences, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Revvity, Inc.
  • S2 Genomics, Inc.
  • Scale Biosciences, Inc.
  • SeqMatic LLC
  • Singular Genomics Systems, Inc.
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation
Product Code: MRR-FB6C9E7932C7

The RNA Analysis/Transcriptomics Market is projected to grow by USD 20.84 billion at a CAGR of 12.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.27 billion
Estimated Year [2026] USD 10.39 billion
Forecast Year [2032] USD 20.84 billion
CAGR (%) 12.26%

RNA analysis and transcriptomics have moved from specialized research workflows into core decision-making tools across life sciences, clinical research, drug discovery, agriculture, and public health. By measuring RNA expression, alternative splicing, fusion transcripts, non-coding RNA, and single-cell gene activity, transcriptomic technologies help researchers understand how genomes are functionally expressed across tissues, disease states, developmental stages, and treatment responses. The field is being shaped by next-generation sequencing, quantitative PCR, digital PCR, spatial transcriptomics, single-cell RNA sequencing, long-read sequencing, and bioinformatics pipelines that convert complex molecular signals into actionable biological insight.

Demand is being reinforced by the shift toward precision medicine, biomarker discovery, immunology research, oncology profiling, infectious disease surveillance, rare disease investigation, and multi-omics integration. RNA sequencing and transcriptome analysis are increasingly used to identify therapeutic targets, stratify patients, monitor pathway activity, and evaluate drug response. At the same time, laboratories are prioritizing reproducibility, sample quality, automated library preparation, secure data management, and standardized computational workflows. As transcriptomics becomes more embedded in translational and clinical research, success depends on balancing analytical depth, scalability, regulatory readiness, and interpretability.

Transformative Shifts in the RNA Analysis Landscape

The RNA analysis and transcriptomics landscape is undergoing transformative change as workflows evolve from bulk gene expression profiling toward higher-resolution, context-aware molecular analysis. Single-cell RNA sequencing is enabling researchers to capture cell heterogeneity that bulk methods can mask, while spatial transcriptomics is adding tissue architecture to gene expression data. Long-read transcript sequencing is improving isoform detection, fusion transcript identification, and transcript assembly, supporting more complete characterization of complex biological systems.

Automation is reshaping laboratory productivity by reducing manual variability in RNA extraction, quality control, library preparation, and sequencing setup. Cloud-enabled bioinformatics and workflow orchestration are making large-scale transcriptome data processing more accessible, though they also increase the importance of data governance, cybersecurity, and auditability. Multi-omics integration is another defining shift, as transcriptomics is increasingly analyzed alongside genomics, epigenomics, proteomics, metabolomics, and clinical phenotype data to generate more comprehensive disease models. Regulatory expectations are also maturing, particularly for clinical-grade assays, companion diagnostic development, and laboratory-developed tests, making validation, traceability, and quality management central to adoption.

Cumulative Impact of Artificial Intelligence on Transcriptomics

Artificial intelligence is accelerating transcriptomics by improving pattern recognition, feature selection, data normalization, cell-type annotation, pathway interpretation, and predictive modeling. Machine learning models are increasingly applied to RNA sequencing datasets to uncover disease signatures, classify molecular subtypes, predict treatment response, and prioritize candidate biomarkers. AI-assisted analysis is especially valuable in single-cell and spatial transcriptomics, where high-dimensional datasets require advanced clustering, denoising, segmentation, and integration across samples, platforms, and modalities.

The cumulative impact of artificial intelligence is not limited to downstream analytics. AI is supporting experimental design, sample quality assessment, read alignment optimization, batch effect correction, and automated report generation. In drug discovery and translational research, AI-driven transcriptomic signatures can help connect mechanisms of action with phenotypic outcomes and support target validation. However, responsible adoption requires transparent model performance, explainability, representative training datasets, bias monitoring, and compliance with privacy and research ethics requirements. Organizations that combine robust laboratory protocols with validated AI-enabled bioinformatics are better positioned to turn RNA expression data into clinically and commercially relevant insight.

Key Regional Insights for RNA Analysis and Transcriptomics

Asia-Pacific is rapidly advancing in RNA analysis and transcriptomics due to expanding genomics infrastructure, rising investment in biomedical research, large patient populations, and increasing adoption of next-generation sequencing in oncology, infectious disease, reproductive health, and population genomics. Countries across the region are strengthening sequencing capacity, bioinformatics talent, and translational research networks, while demand for cost-efficient, scalable workflows supports broader deployment of RNA sequencing and molecular diagnostics.

North America remains a major innovation hub for transcriptomics, supported by strong academic research, clinical trial activity, precision medicine initiatives, established sequencing infrastructure, and advanced bioinformatics capabilities. The region has deep adoption across oncology, immunology, neuroscience, rare disease research, and drug development, with growing emphasis on single-cell, spatial, and multi-omics approaches.

Latin America is gaining traction as research institutions and healthcare systems expand molecular testing capacity and genomics collaborations. Adoption is being encouraged by infectious disease research, cancer genomics, agricultural biotechnology, and public health applications, although uneven infrastructure and specialized workforce availability influence implementation across countries. Europe shows strong progress through coordinated research programs, biobanking networks, data protection frameworks, and clinical genomics initiatives. European laboratories are emphasizing assay quality, interoperability, ethical data use, and regulatory alignment, particularly for clinical and translational applications.

The Middle East is increasing its focus on genomics and precision medicine through national health transformation strategies, population genomics programs, and investment in advanced laboratory capabilities. Transcriptomics is gaining relevance in inherited disease research, oncology, and personalized healthcare. Africa is at an earlier but important stage of transcriptomics adoption, with opportunities tied to infectious disease surveillance, population diversity research, antimicrobial resistance, agriculture, and capacity building. Sustainable growth across Africa depends on strengthening sequencing infrastructure, local bioinformatics expertise, sample logistics, funding continuity, and equitable research partnerships.

Key Group Insights Across Global Transcriptomics Ecosystems

ASEAN is emerging as a strategically important group for RNA analysis and transcriptomics as member economies invest in biotechnology, infectious disease monitoring, oncology research, and academic genomics capacity. The region's genetic diversity and public health priorities create strong scientific rationale for transcriptomic research, while cross-border collaboration can improve data harmonization, training, and access to advanced sequencing services.

The GCC is advancing transcriptomics through healthcare modernization, national genomics initiatives, precision medicine programs, and investment in specialized clinical laboratories. Strong interest in inherited disorders, cancer, metabolic disease, and population-specific reference data is increasing the relevance of RNA-based analysis in translational and clinical research. The European Union provides a highly structured environment for transcriptomics, supported by research funding frameworks, cross-country data initiatives, biobanking infrastructure, and regulatory emphasis on privacy, quality, and reproducibility. EU-based adoption is closely linked to multi-center studies, rare disease networks, cancer research, and clinical genomics integration.

BRICS countries represent a diverse but influential grouping, combining large populations, expanding sequencing capabilities, and growing biomedical research ecosystems. Transcriptomics adoption across these economies is supported by needs in infectious disease, oncology, agriculture, pharmacogenomics, and public health, though infrastructure maturity and regulatory pathways vary by country. G7 countries maintain strong leadership in advanced transcriptomic applications due to mature research institutions, translational medicine programs, pharmaceutical research activity, and established clinical sequencing ecosystems. NATO members, while not a health or science bloc, collectively include many countries with advanced biomedical infrastructure, biosecurity interests, and public health preparedness priorities, making RNA analysis relevant to pathogen surveillance, resilience planning, and defense-related bioscience research.

Key Country Insights Shaping Transcriptomics Adoption

The United States is a leading center for RNA analysis and transcriptomics, driven by extensive biomedical research funding, clinical genomics adoption, pharmaceutical development, cancer research, and advanced sequencing and bioinformatics infrastructure. Canada is strengthening transcriptomics through academic research networks, precision health initiatives, population studies, and biobanking programs, with emphasis on ethical data governance and collaborative science. Mexico is expanding molecular research capacity in infectious disease, cancer, and agricultural biotechnology, while access to advanced sequencing and trained bioinformatics professionals remains a key determinant of broader adoption. Brazil is an important Latin American contributor, supported by public health genomics, infectious disease research, oncology studies, biodiversity research, and growing sequencing expertise.

The United Kingdom continues to advance transcriptomics through genomic medicine programs, research hospitals, biobanks, and strong capabilities in clinical and population-scale omics. Germany demonstrates strength in translational research, molecular diagnostics, industrial biotechnology, and clinical laboratory quality systems, while France supports transcriptomics through national research institutions, cancer programs, rare disease initiatives, and multi-omics collaborations. Russia has capabilities in molecular biology, infectious disease research, and academic genomics, with adoption influenced by infrastructure access and international collaboration dynamics. Italy and Spain are both active in cancer research, immunology, rare disease studies, and clinical genomics, with expanding use of RNA sequencing in translational and academic settings.

China has rapidly built transcriptomics capacity through large-scale sequencing infrastructure, biomedical research investment, population studies, oncology research, infectious disease surveillance, and agricultural genomics. India is gaining momentum due to expanding genomics programs, cost-sensitive sequencing innovation, infectious disease priorities, oncology research, and a growing bioinformatics workforce. Japan has a strong foundation in precision medicine, regenerative medicine, aging research, oncology, and single-cell analysis, supported by high-quality research infrastructure. Australia is advancing transcriptomics through medical research institutes, population health studies, cancer genomics, infectious disease preparedness, and agricultural biotechnology. South Korea is a major adopter of advanced sequencing, supported by precision medicine initiatives, strong biotechnology infrastructure, cancer research, and digital health integration.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize end-to-end workflow reliability, from RNA sample preservation and extraction through library preparation, sequencing, analysis, and reporting. Investments in automation, quality control, and standardized protocols can reduce variability and improve reproducibility across research and clinical environments. Organizations should also strengthen bioinformatics capabilities by adopting validated pipelines for differential expression analysis, single-cell RNA sequencing, spatial transcriptomics, long-read transcriptomics, and multi-omics integration.

To capture value from AI-enabled transcriptomics, leaders should build governance frameworks that address model validation, explainability, data privacy, and bias mitigation. Strategic partnerships with academic centers, healthcare networks, and public health institutions can improve access to diverse datasets and clinically relevant samples. For clinical translation, assay developers should align early with regulatory, quality management, and data security requirements. Companies and laboratories should also invest in workforce development, including molecular biology, computational biology, biostatistics, and clinical interpretation skills. Finally, global expansion strategies should be tailored to local infrastructure, reimbursement dynamics, regulatory maturity, and research priorities rather than relying on one-size-fits-all deployment models.

Research Methodology for Transcriptomics Insights

This executive summary is developed through a structured secondary research approach focused on verified, publicly available, and data-backed sources relevant to RNA analysis and transcriptomics. The methodology considers scientific literature, clinical research trends, regulatory guidance, public health genomics initiatives, technology adoption patterns, academic and government research programs, and evidence from recognized life sciences and molecular diagnostics domains. Emphasis is placed on qualitative validation of industry dynamics rather than market estimation, market sizing, market share, or forecasting.

The research process includes triangulation across peer-reviewed publications, genomics program documentation, regulatory and standards-related references, healthcare and biotechnology policy developments, and regional research ecosystem indicators. Insights are organized by technology evolution, application areas, regional adoption patterns, group-level dynamics, and country-specific research capacity. The analysis also incorporates cross-cutting factors such as sequencing infrastructure, bioinformatics readiness, clinical translation, data governance, workforce availability, and AI-enabled analytics. All findings are synthesized to support strategic interpretation for stakeholders in research, diagnostics, biotechnology, pharmaceutical development, public health, and precision medicine.

Conclusion: Strategic Outlook for RNA Analysis and Transcriptomics

RNA analysis and transcriptomics are becoming essential to understanding biological function, disease mechanisms, therapeutic response, and cellular diversity. The field is progressing beyond conventional gene expression analysis toward single-cell, spatial, long-read, and AI-enabled approaches that provide richer biological context and improve translational relevance. As adoption expands across research, clinical, agricultural, and public health settings, the most successful organizations will be those that combine high-quality laboratory workflows with scalable analytics, strong data governance, and interdisciplinary expertise.

Regional and country-level momentum reflects different priorities, from precision medicine and cancer research to infectious disease surveillance, population genomics, inherited disease studies, and biotechnology innovation. While infrastructure, regulation, funding, and workforce readiness vary globally, the strategic importance of transcriptomics continues to rise. Stakeholders that invest in reproducible methods, validated bioinformatics, responsible AI, and collaborative ecosystems will be well positioned to convert RNA-derived insights into measurable scientific and clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. RNA Analysis/Transcriptomics Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables & Reagents
  • 7.3. Instruments
  • 7.4. Software & Services

8. RNA Analysis/Transcriptomics Market, by Technology

  • 8.1. Introduction
  • 8.2. Digital PCR
  • 8.3. Microarray
  • 8.4. Next Generation Sequencing
    • 8.4.1. Bulk Transcriptomics
    • 8.4.2. Single Cell Transcriptomics
      • 8.4.2.1. Droplet Based
      • 8.4.2.2. Microfluidics Based
  • 8.5. Real Time PCR

9. RNA Analysis/Transcriptomics Market, by RNA Type

  • 9.1. Introduction
  • 9.2. Messenger RNA
  • 9.3. MicroRNA
  • 9.4. Transfer RNA
  • 9.5. Ribosomal RNA

10. RNA Analysis/Transcriptomics Market, by Sequencing Scale

  • 10.1. Introduction
  • 10.2. Low-Throughput
  • 10.3. Medium-Throughput
  • 10.4. High-Throughput
  • 10.5. Ultra-High-Throughput

11. RNA Analysis/Transcriptomics Market, by Application

  • 11.1. Introduction
  • 11.2. Cancer Research
  • 11.3. Drug Discovery
  • 11.4. Genetic Testing
    • 11.4.1. Carrier Screening
    • 11.4.2. Disease Diagnostics
    • 11.4.3. Prenatal & Newborn Testing
  • 11.5. Infectious Disease Research
  • 11.6. Plant Research

12. RNA Analysis/Transcriptomics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. RNA Analysis/Transcriptomics Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. RNA Analysis/Transcriptomics Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 10x Genomics, Inc.
  • 16.2. Agilent Technologies, Inc.
  • 16.3. Azenta, Inc.
  • 16.4. BGI Genomics Co., Ltd.
  • 16.5. Bio-Rad Laboratories, Inc.
  • 16.6. BioSkryb Genomics, Inc.
  • 16.7. Curio Bioscience, Inc.
  • 16.8. Danaher Corporation
  • 16.9. F. Hoffmann-La Roche Ltd.
  • 16.10. Genewiz, Inc.
  • 16.11. Illumina, Inc.
  • 16.12. Lexogen GmbH
  • 16.13. Merck KGaA
  • 16.14. Mission Bio, Inc.
  • 16.15. NanoString Technologies, Inc.
  • 16.16. New England Biolabs, Inc.
  • 16.17. Oxford Nanopore Technologies plc
  • 16.18. Pacific Biosciences of California, Inc.
  • 16.19. Parse Biosciences, Inc.
  • 16.20. Promega Corporation
  • 16.21. QIAGEN N.V.
  • 16.22. Revvity, Inc.
  • 16.23. S2 Genomics, Inc.
  • 16.24. Scale Biosciences, Inc.
  • 16.25. SeqMatic LLC
  • 16.26. Singular Genomics Systems, Inc.
  • 16.27. Standard BioTools Inc.
  • 16.28. Takara Bio Inc.
  • 16.29. Thermo Fisher Scientific Inc.
  • 16.30. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DROPLET BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DROPLET BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DROPLET BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICROFLUIDICS BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROFLUIDICS BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROFLUIDICS BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REAL TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REAL TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REAL TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MESSENGER RNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MESSENGER RNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MESSENGER RNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MICRORNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSFER RNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRANSFER RNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRANSFER RNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RIBOSOMAL RNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RIBOSOMAL RNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RIBOSOMAL RNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ULTRA-HIGH-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ULTRA-HIGH-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ULTRA-HIGH-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CANCER RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CANCER RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CANCER RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARRIER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PRENATAL & NEWBORN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PRENATAL & NEWBORN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PRENATAL & NEWBORN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INFECTIOUS DISEASE RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INFECTIOUS DISEASE RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INFECTIOUS DISEASE RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PLANT RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLANT RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PLANT RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 149. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 150. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. NATO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 156. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 158. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 159. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 190. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 194. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 218. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 222. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 223. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 225. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 231. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 232. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 234. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 241. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 243. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 254. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 256. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 258. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 259. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 268. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 270. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 272. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 274. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 276. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 277. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 279. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 295. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 303. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 304. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 306. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 326. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 328. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING SCALE, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN RNA ANAL